| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | ||||||
| REV | 4.710M | 0 | -4.710M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Imunon (NASDAQ:IMNN).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Thursday, September 29, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $6.2 last updated February 8, 2023 at 8:51 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q2 earnings are confirmed for Tuesday, February 21, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | ||||||
| REV | 4.710M | 0 | -4.710M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Imunon (NASDAQ:IMNN).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Thursday, September 29, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $6.2 last updated February 8, 2023 at 8:51 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q2 earnings are confirmed for Tuesday, February 21, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | ||||||
| REV | 4.710M | 0 | -4.710M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Imunon (NASDAQ:IMNN).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Thursday, September 29, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $6.2 last updated February 8, 2023 at 8:51 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q2 earnings are confirmed for Tuesday, February 21, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | ||||||
| REV | 4.710M | 0 | -4.710M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Imunon (NASDAQ:IMNN).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Thursday, September 29, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $6.2 last updated February 8, 2023 at 8:51 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q2 earnings are confirmed for Tuesday, February 21, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | ||||||
| REV | 4.710M | 0 | -4.710M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Imunon (NASDAQ:IMNN).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Thursday, September 29, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $6.2 last updated February 8, 2023 at 8:51 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q2 earnings are confirmed for Tuesday, February 21, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | ||||||
| REV | 4.710M | 0 | -4.710M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Imunon (NASDAQ:IMNN).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Thursday, September 29, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $6.2 last updated February 8, 2023 at 8:51 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q2 earnings are confirmed for Tuesday, February 21, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | ||||||
| REV | 4.710M | 0 | -4.710M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Imunon (NASDAQ:IMNN).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Thursday, September 29, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $6.2 last updated February 8, 2023 at 8:51 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q2 earnings are confirmed for Tuesday, February 21, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | ||||||
| REV | 4.710M | 0 | -4.710M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Imunon (NASDAQ:IMNN).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Thursday, September 29, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $6.2 last updated February 8, 2023 at 8:51 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q2 earnings are confirmed for Tuesday, February 21, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Day Range6.200 - 6.940 | 52 Wk Range3.502 - 42.000 | Open / Close6.560 / 6.430 | Float / Outstanding1.608M / 1.616M |
| Vol / Avg.17.123K / 385.332K | Mkt Cap10.020M | P/E- | 50d Avg. Price7.730 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float1.608M | EPS-17.000 |
Earnings
see more| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-21 | ||||||
| REV | |||||||
| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | ||||||
| REV | 4.710M | 0 | -4.710M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Imunon (NASDAQ:IMNN).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Thursday, September 29, 2022. The analyst firm set a price target for 0.00 expecting KTRA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $6.2 last updated February 8, 2023 at 8:51 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There are no upcoming dividends for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q2 earnings are confirmed for Tuesday, February 21, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.